Kognitif Füzyon Prostat Biyopsisinde Deneyim Kanser Tespit Oranını Etkiliyor Mu? İlk ve Son 60 Vakanın Karşılaştırılması

Objective: We aimed to determine the contribution of clinical experience gained in cognitive fusion prostate biopsy with increase number cases cancer detection rate. Materials and Methods: The records 120 patients who underwent were retrospectively analyzed. All 3-T multiparametric magnetic resonance imaging (Mp-MRI) they evaluated Prostate Imaging Reporting Data System (PIRADS). initial 60 included group 1, later subsequent performed by same surgeon 2. Any clinically significant (CSPrCa) rates groups 1 2 compared. Results: mean ages for determined as 64.08 ± 8.15 65.15 6.93 years, respectively. Age, specific antigen (PSA), volumes suspicious lesions similar. positivity rate was 33.3% 40% 2, without any intergroup difference (p=0.494). CSPrCa 70.83% respectively, there a improvement favor (p=0.027). Conclusion: Regarding biopsies, learning curve is required. It concluded that detecting almost doubled increased biopsy. Keywords: Biopsy, Cognitive Fusion, Learning Curve, Magnetic Resonance Imaging, Cancer